MUSGROVE LKL'KAEMIC GROLTP SO.MERSET RaA%ing funds for the benefit of Patlents in SomcrseÉ UNAUDITED FINNcIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2026 R'4 GISTERED CHARITY NUMBER 1036580
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Patients ID Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 28 FEBRUARY 2026 REFERENCE AND ADMIMSTRATIOIY DETAILS Charity name: Regist¢red Charity number.. Charity's principaI address: Musgrove La&aemic Gmup Sornerset 1036580 16 ]cIgh Road BRIDGWATER Somerset TA6 7HR Trustec5: Mrs Patricia Re&J (Chairy)erson) Miss JaneAllin (Secretary) Fth Maureffl Hudson Mrs Margaret Smith Mr Bernard Reed (Treasurer) Mrs Pat Cornish David Edwards Professional Advisors Bankers: National Westminster Bank plc 26127 Fore Street TAUNTON Somersel Independent Examin¢r: Monah8ns Chartered A¢count4nts 6th Floor Whitefriat3 BRISTOL BSI 2Nr STRUCTURE COVERNANCE AND MAliAGEMENT Musgrove Leukaernic Group Som¢rset is a registered charity and has been Constitut as an uliincorporated association govemed by a fomial constitution. A copy of the constitution may be obtain¢d on application to the Secrelary. Trnste are elected at cach Annual General Meeting but retiTing Truste&s are eligible for Te- el¢¢tion. The Ofiicers may hold office until Tetir¢ment or by removal at an Am]ual General Meetin& Co-opted Trustees may be appointed by the Committee at any time and g¢nerally have special knowledg¢ or experien(% with leukaemia or relatol conditions. They may serve for sucl) period as d¢cided by the Committee or by tl)eir retiremenl.
tUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Patients in Som¢rset TRUSTEES ANNUAL REpoirf FOR YEAR EfiDED 28 FEBRUARY 2026 (continued) OBJECTIVES AND ACTIVlEs The Charity's Objecti& and activiliesfor the Public Benefv The objects of the Group are to reliev¢ persons suffering frotn Leukaemia and associated conditions by assisting and funding thc treatm&)ts and welfare of such persons at Musgrove Park Hospital, Taunton Somerset or any other area aUthOris by the rnedica] staff. The Group carries out thes¢ objeds by: Sponsoring the medical staff that are considered key by the Somerset NHS Foundation Trust to maintaining Muswve Park Hospital as a centre for the trcatm¢nt of Leukaemia and other related diseas&8. The grants made to nursing staff for training ar¢ in an aspect which when ci)mpleted will enhance the experience of Leukaemia patients whilst receiving trealrnent for L¢ukaemia and other r¢lated diseases. The purchase of equipment and furnitur¢ is made following recommendations from thc rn¢dical staff with a view to improving the quality of th¢ treatm¢nt and the notiOnal and physical well- being of both suffers and relativ¢8. Charity Ory(misalion and History The Musgrove LeUkal¢ Group Somerset was launched in 1978 and is run completely by unpaid volunteern who abso all their own pers(Inal expenses. There are no paid office and overheads are kept to an absolute minimum ther¢by ensuring that most of the fLmds raised goes. to the Haernatology Unit at Musgrove Patk Hospital, Taunton. The hospitsl b&s become a major centre in the South West for the diagnosis and treatment of Icuka¢mia and relat blo(Kl disordet3. Jn g¢neral, the aims of the Group are &8 follows: To maintain Musgrove Park Hospital as a major centre for the diagnosis and treatment of leuka¢mia and related blood disorders by the most upto4ate t¢¢hniques. ii) 'fo keep the public infornied on progress being made on the diagnosis and treatment of these diseases. Tlie Group meets regularly in Bridgwat¢r and Taunton.
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Patients in Somerset TRUSTEES ANNUAL REpoKf FOR THF YEAR ENDED 28 FEBRUARY 2026 (coJAlinued) Policy is discussed at both Group and Committee meetings, but th¢ Comn)ittee has the duty to manage the Group and the w)wer to ultimately make executive decisions. The Gmup has area representative6 coveTing Somerset at Bridgwatcr, Bumham on Seffj Chard and I]minster, Min¢ht¥d, Tauntoffj and Wellington. The area rq)resentatives act as local contacts organising events and visiting various businesses, people or other organisations as requir&l. In turn they report back to Gruup meetings on a regular basis. ACHtEVEMENfs AND PERFORMANCE Chairperson'sReport The ambulatory room in Ward 9 h&s establisbed a successful way of pmviding treatinent to those patients not rt4uiring to be seen as in-patients. freeing up bed space for those who rcquire oiie. S¢v¢ral patieiits need to travel substantial distance to receive their treatmenL so the Truqtees are now in discussions with the N'HS Tmst to provid¢ accomm(MJation in Taunton for those patients undergoing treatment. This will improve patient well-being. The wnvfftyion of the condemned batFff(K)m on Ward 9 to a new wet room has completed and can)¢ in under budget by £3,121 at £34,534, this c05t was accrued in the 2025 awounts. The Hardship fimd hAS assisted 30 pati¢nts to date with various expaL8&8 tota]ing £13,268. The MusgTove Leukaemic Group hav¢ approved a new 3-year sponwrship of a pool car, which commen¢cd in October 2025. to enable the hematology nurses to provide ¢h¢moth¢rapy to patients in Bridgwater and Wellington hospitals. Four new chemotherapy chairs have been purGhascAI for Williton Hospitsl to improve the patient's experience. The Gmup continue to the sponsorship of Kelly Savva as a Teflexologist on Ward 9. The NHS trust is now paying th¢ fi1 salary of th¢ nurse practitioner. The Group's website h&s been revamped and is live. It will be updat&l. Funds are held to support these projects and any oth¢r proj¢ct that falls within our constitution to cnabl¢ th¢ Taunton and Somerset NHS Foundation Trust to meet th¢ ne]S of the pati¢nts. I would like to thank the officers and comrnittee mffl]bers for their continued commitm¢nt. TrSela Reed Chairperson
MUSGROVE LEUKAEMIC GROUP SOMERSET Ralsing funds for the benefit of Patients in Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 28 FEBRUARY 2026 (continued) Consultanl's Report Hello to all and another year which seems to have flown by. I am pleased to report that the MLGS cAyntinues to r¢main strong. Once again, l am so grnt¢fuJ to all the volunteers and Trustees and especially Bernard to continue to run the charity. It always astounds me the amount of good will needed to rLm such an organisation and to all the donors who contribute so g¢n¢rously. AS clinicians we continue to strive to offer the best care to OUT paticnts in Somerset. As ¢ver th¢ demands of the NHS continue to grow. Much of tbis repr¢s¢nts success with more patients able to be offered a range of ever-increasing novel therapies. Many of which have very acceptablellimited side effect profil&8 rnaking it available to a larg¢r number including frailer pati¢nts. Not only do these drugs improve qualAty of life but also survival rates. This hug¢ increase in capactty requires increase in staff and estat and we seem to be growing rapidly out of building ¢v¢n from the relatively new builds. The deparbnent has seen stable staffing levels and been ¢ible to keep up with the demands of the ever-in¢rcasing service. I mnain grateful to staff for their pn)fessiona]ism and as such we are pl¢ased to support them where we can. Support continues in providing furnishings such as Teclining chairs for patienls for the B¢acon Day uniL ambulatory care unit and our district hospitals. The hardship fvnd continues to provide a source of vital funds especially for travel and parking for a cohort of patients and has also been extended to our younger TYA population. The outreach chemo car lease continues to provide a valuable service of delivering treatment to patients locally. W¢ have b¢en able to 5UPPOrt upgrade equipment for the stem cell transplant scrvicc. As referred to earlier the issues with capacity and the lack of &stat&g is becorning a major issue in our quest to offff th¢ b¢st care to our patients, and we are actively looking at how to supwrt the department with major investments in this area. I hope to be able to update this in du¢ courJ¢. As ever, I remain overwhelmed by th¢ generosity of the local population with all th¢ donations as well as the time and effort of fjjnd raising. We will continue to support our pUlatIOn with these funds as we strive to provide the best Haematology c4r¢ in the county. Deepak Mannari Consultant H2eMatol0 07 May 2026.
MUSGROVE LEUKAEIMIC GROUP SOMERSET Raising funds for the benefit of Patients in Somerset TRUSTEES ANNUAL REpoKf FOR THE YEAR 'DED 28 FEBRUARY 2026 (continued) FINANCIAL REVIEW Treasurers Report The total raised for the year ended 28 Febnry 2026 amount to £47,746. The total expenditure for the year ended 28 February 2026 is £30,975. The total raised since fonnation as of the 28 of February 2026 is £4,179,552. The year ending February 2tY26 has seen a level of fundraising that is consistent with the Groups lin)ited ability to generate fijnds. The continued support of our regular contributOTS, donors, and frifflds plus the dedicated work of the Trnstees and Members is essential to enable the Group to continue to support projects at Musgrove Park Hospitsl. The cost of the conversion of the condcmned bathmom on Ward 9 to a wet room was quoted at £38,540, it came in under budg¢t at £34,534. There remains a retention of £885 to b¢ paid in August 2026 and therefor¢ there h&8 b¢¢n an accrual rcversaj of £3,121. Discussions have commen¢¢d with the maj11 team reganling providing ac(x>n]modation for those patients receiving treatment in the ambulatory room that liv¢ substantial distsnce from the hospital, this project would rquire the Group providing a substantial grant. The Trustees, m¢mb¢rs and volunteers absolb all their own expense4 so overheads are minima] and are CUTtlY under Iyo of funds raiscd. The Musgrov¢ L¢uka¢mi¢ Group somset is in a sound financial position because of the retain¢d nd5 held. Detailed accounts are attach for inspection.
MUSGROVE LEUKAEMIC GROUP SOMERSET Raisillg funds for the benelh of P8tieDts in Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 28 FEBRUARY 2026 (continued) Reserv&s Polley Musgrove Lcukaemic Group Somerset (MLGS) retsins r¢s¢rv¢s, and this document explains our policy. In defining this policy, the TSt have considered: l) Income forecasts for future years considffing the r¢liability of each source of income and the potential for securing new income from alternative sources. 2} Expenditure forecasts for tr¢ y¢ars. 3) The need to hold reserves should a m¢dical breakthrough necessitste the urgent pUrchC of new equipment. 4) Th¢ ned to hold r¢S¢ry to m¢¢t our immfyliate commitmfflts should income levels drastically fall. Th¢ Group attempts to maintsin r¢s¢rves of approximately £2(K),(KK). which is rq)resented'by cash on sbort-terni deposit and in the Group bank accounts. The presalt level of retsin ndS results from s¢v¢ra] 1¢ga¢1 rec¢ived in th¢ financial year ending 2022, it is not the ttustee's intention to hold these funds as reserv&8. Th¢ Trust¢e's are in d]Ussion wilh the NHS trust regarding establishing accommodation for patients using ihe ambulatory room for treatmenL this project would requir¢ a substantxal grant from th¢ MLGS, thus rcducing th¢ fimds h¢ld. The Group believes it is prudent to ke this level of surplu8 to: l) Bnsure the Group Can maintaili its comn]ittnent to fund rcsearch salari¢s and consumables for year periods and to be able to so even if income levels should substantially fall for a period sufficient to allow altnative arrangements to be made. 2) To provide equipment on urgfflt requ&st if the ne¢d should arise. 3) To act as a buffer against any unforeseen eventuality. Our levels of resffves are constantly monitord and revieweAI both at GTOUP meetings and Cominittee me£tings. The present level of Reserves is considerfyl appropriate to enable the Group to m¢¢t our commitments for the fmancial year dIng 2027. The legaci&% received in 2022 h&8 Tesulta in the Musgrov¢ L¢ukaani¢ Group Som¢rs¢t being in a strong fIn]cial position. Bernard Reed Hon. Treasurer.
MUSGROVE LEUKAEMIC GROUP SO.MERSET Raising funds for the benefit of Pallents in Somerset TRUSTEES AINNUAL REPORT FOR THE YEAR ENDED 28 FEBRUARY 2026 (continued) Trustees, annual report The Musgrove Leukaemic Group Somerset (MLGS) was fornied in April 1978 by parents whose children were vnd¢rgoing treatment for leukaemi& Due to the limit[ faciliti¢s at Musgrove Park Hospital they had to visit hospitals in southamOn and Bristol for treatm¢nt, placing severe strain on the fatnili¢s, The Present Truste6s are a group of p¢oplc continuing to fijndratse to improve tbe fa¢iliti&s for leukaemia and lymphoma patients and their families in Somffset. The fiwds rais by Ihe MLGS are utiliS to purchas quipment for the wards to improve the experi¢n¢¢ of patients whilst undergoing treatment. The MLGS has now raisd over £4 Million, 950/0 of which hasfis being made available to Musgrov¢ Park 14ospitals' HaematologylOn¢ology and Children's Lnit becau all the Trustees and mernb¢rs services are voluntary. The Tte¢S will WOTk with th¢ Ml¢al team to provide facilities to improve the patient experience whilst they are receiving treatment. The funds are rnised by various means but principally from donations including legacies, collections, and other fLdraiSing eveuts. Ow aim is to continue to rdiS¢ fimds to improve the hospital experience for leukaemia and lymphoma patients.
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Patients in Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 28 FEBRUARY 2026 (continued) STATEMENT OF TRUSTELS RESPONSIBILITIES Charity law requires th¢ trust to prepare fmancial statements for each financial y¢ar which show a true and fair view of the state of affairs of the charity and its financial aclivities for that period. In ' preparing those financial statements, the trust¢¢s are required to Select suitable accounting poIicies and then apply them coiisistently" Make judg¢m¢nts and estimat&s that are reasonable and pnulent; Stst¢ whether applicable acUntIng standards and statements of rornmended practice have been followed, subject to any departure disclosed and explain in the financial statemsllts, and Prepare the financial statements on the going Concern basis unles5 it is inappropriate to presLmie that the charity will continue in operational existenc¢. The Trustees are responsibl¢ for keeping pruper accounting records which disclose with reasoiiable aCracY at any time the financial wsition of the charity and to enable thtin to ensure that th¢ financial stat¢ments cornply with the ChaTities Act 2011. They are also responsible for saf¢guardin8 the aets of th¢ charity and hence for tAking re&8onable steps for tlie pr¢v¢ntion and detection of fraud and other irreguIarities. DECLARATION The TnTst¢48 declare that they have apprnV the Thjstees, Rqx)rt. Signed on behalf of the chwity's trust¢¢s: Tricia Reed Chair
MUSGROVE LEUKAEMIC GROUP SOMERSET Raislng funds for the benefit of Pallents ID Somerset Independent Exarniner's Report to the Tnvtstees of Musgrove Leukaemic Group Somerset I reEx)rt on the accounts of Musgrove Leukaemi¢ Group Somerset for the year ended 28 February 2026 which are set out on pagas l O 10 14. Respe¢tive responslbilities of trustees and examiner Tli¢ charity's trustees are K8ponsible for the preparation of the accounts. The charity's tsvstees consider that an audit is not requireil for tbis year under se¢tion 144 of the Charities Act 2011 (the Charities Act) and that an indq)¢ndcnt examination is neal¢d. It is my responsibility to: examin¢ the accounts undcr section 145 of the Charities Act. to follow the procedures laid down in the general Directions given by the Charity Commissioners (under seclion 145 (5) (b) of the Charities Act). and to state whether particular matteL3 have come to my attention. Basi8 of independent examiner's report My examination was &grrid out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting re(xTrrds kept by the charity and a coniparison of the accounts presentaj with those records. It also includes ¢onsideration of any unusual items or disclosures in the accounts and seeking explanations from you as trnstees coiicerning any suth matt¢rs. The procedures undataken do not provide all the evidence that would be required in an audit, and consequ¢nily no opinion is given as to whether the accounts present a 'true and fair, vie1 and th¢ rert is limited to those matters set out in the statement below. Jndependent examiner's statement In connection with my examination, no mattw has come to my attention: i) which giva8 rne reasonable caus¢ to believe that in, any material respe¢l the requirements to keep aCUnting rccords in accordance with section 130 of the Chariti&s Act. and to prepare accounts whi¢h accord with the aw)unting rec4)rds and comply with the accounting requirements of the Chariti&8 Act have not been m¢: or 2) to which, in my opinion, attention shou]d be drdwn in order to enable a proper understanding of the accounts to be r¢ached. Mark Powell Monalians 6 Floor INhitefriars Lewins Mead Bristol BSI 2NT Date: Ir r_ 2•1
MUSGROVE LEUKAEMIC GROLP SOMERSET Raislng funds for the benefit of Patlents in Somerset STATEMENf OF FllYLNCIALACTtVlTIES FOR THE YEAR ENDED 28 FEBRUARY 2026 LMr¢stricted Restrlcted Total Funds Total Funds Funds Funds 2026 2025 INCOME & EXPENDITURE Incomning Resources Donations, legacies and similar incorning resour. Donations Fund Raising Collections Covenants & Gifi Aid (including tax recover1) 7,529 9,945 1.299 7,529 9,945 1,299 12,043 6,355 1,142 2,039 2,039 1,920 Investment Income: Bank Interest 26,934 26,934 33,149 TOTAL INCOMING RESOURCES 47.746 47,746 54,609 Resources Expended ote Direct Charitabl¢ Expenditure 2 Fund Raising and Publicity Management and Administration 29,486 29,486 196 93,425 681 1,293 1393 1,090 TOTAL RESOURCES EXPENDED 30,975 30,975 95,196 NET (OUDIIYFLOW OF RESOURCES FOR THE YEAR AND MOVEMENf 11¥4 FUNDS 16.771 16,771 (40,58D BaIan brought forward at l March 2025 870,682 870,682 911,269 BAI.ANCES CARRIED FORWARD AT 28 FEBRUARY 2026 887,453 887,453 870,682 10
MUSGROVE LEUKAEMIC GROUP SOMERSET Ralsing funds for the benefit of Patients in Somerset BALANCE SHEET AS AT 28 FEBRUARY 2026 2026 2025 Note CURREI¥T ASSETS DebtorJ Short tern) deposits Cash at bank and in hand 657 825,951 69,946 623 800,000 114,174 896J54 914,797 CREDTTORS: Amounts falling due within one year 9,101 44,115 TOTAL NET ASSETS 887,453 870,682 Funded by: UNRESTRicfED FUNDS General Fund 887,453 870,682 Th&8e accounts approved by the Truste¢s on. / o frL foN<20 Bernard Reed Treasurer For And on behalf of the Trustees Jan¢ A Secretary
MUSGROVE LEUKALMIC GROUP SOMERSET Raising funds for the benefit of Patients Ill Somerset NOTES TO THE ACCOU.Yrs FOR THE YEAR ENDFD 28 FEBRUARY 2020 ACCOUNTING POLICIES Accounting bas1$ and standards The financial statetnents have been prepared under the historical cost convention and in acrdance with applicable accounting standards, the Charities SORP (FRSI 02) (Accounting and Reporting by Charities) and wmply with the Charities (Accounts and Report5) Regulations 2008 issued under the Charities Act 2011. b) Voluntary Income Voluntary income is receivd from a number of source4 including donations, coll¢¢tions and oth¢r fund raising events. Such inwine is included in full in the incornc and expenditure account when received. Restricted and Unrestricted Funds Where appropriat¢, the accounts distinguish betwe1 restri¢t&J and Unrl¢t¢d funds. The fornler are receiv¢d from donors and are subjecl to restrictions on the puryose for which they may be Us. Unrestrict funds are those where there aTe no externally imp)sd r&strictions which the charity may use at its discretion to achieve it5 objectives. In the opinion of the Officers the Charity do&8 not operat¢ any restricted fimds. Short Term D¢po$lts Short temi deposits repr&sent monies plac on deJK)Sit with National Westminster BaDk Treasury R&seTve Centre. Bank Interest ' Bank Interest is ¢rditeA to the income and ¢xpenditure account wb¢n received. Covenants Covenants are creditcd to the income and expenditure account when received. Provision is mad¢ for recova?ble income tax arising frorn the covenants. 12
IUsGRoVE LEUKAEMIC GROUP SOMERSET Rajsing funds for the benefit of Patients Somerset NOTES TO THE ACCOL'IW3 FOR THE YEAR E,YDED 28 FEBRUARY 2026 (Continued) Taxation Musgrove L¢uka¢mic Group Somerset is a registered charity and the results of its nonnal activiti are not liable to cOrTatiOn tax. Unrestricted Restricted Totsl Funds Total Funds Funds Funds 2026 2025 DIREcf CIIARITABLE EXPENDITURE (Amounts payabl¢ in fi]rtherdn¢¢ of the Charities objects): Clinical unit grants Coinplimentary medicine nts Chernotlittapy wol car grant 17,881 6,875 4,730 17,881 6,875 4,730 90,245 3,180 29,486 29,486 93,425 The above grants were mad¢ in support of Musgrove Park Hospital in Taunton. FUND RAISING AND PUBLICITY Fund raising costs Publications 480 201 196 196 196 196 681 13
MUSCROVE LEUKAE.MIC GROUP SOMERSET Raising fuDds for the benefit of Pydtients in Somerset NOTES TO THE AccouNrs FOR THE YEAR ENDED 28 FEBRUARY 2026 (Continued) Unrestricted Restri¢led Total Funds Total Funds Funds Funds 2026 2025 MANAGF,MENT AND ADIWINISTRATION OF CHARITY Public liability insurdnce Independent examiners f6 Letterhead paper 591 702 591 702 580 480 30 1293 1,293 1,090 DEBTORS Income tax recoverable 657 623 REDITORS: Amounts falllng due withln one year Accountancy a¢cnMI Clinical unil ntS accrual Complim¢ntary M1clne accrual 576 3,630 4,895 450 43,665 9,101 44,115 Balance Net movement Balance 1.3.25 funds 28.2.26 UNREsrcTED FUNDS Geiieral Fund 870,682 16.771 887,453 14